About us
About us
Home
Our membership
Stronger together
Our governance
Our organisation
Our values
Vision and Mission
Meet the team
Your trustees
Our staff
Volunteers and teams
Meet our volunteers
The founders
What we do
Our plans 2022-2025
Campaigning
Ongoing activities
Annual reports
Funders and sponsors
Policies
Our policies
Transparency
Impartiality statement
Privacy statement
Medical disclaimer
About GSD
Types & Causes
What is GSD?
What causes GSD?
Seeking a diagnosis?
The GSD variants
Ultra-rare disease?
Clinical support
Specialist centres
Health policy
UK Rare Disease Strategy
The GSDs
GSD0
Diagnosis & Follow up
Information & Support
Research & Development
Von Gierke (GSD1)
Diagnosis & Follow up
Information & Support
Research & Development
Pompe (GSD2)
Diagnosis & Follow up – Infantile Onset (IOPD)
Diagnosis & Follow up – Late Onset (LOPD)
Information & Support
Pompe Support Team
Research & Development
Cori (GSD3)
Diagnosis & Follow up
Information & Support
Research & Development
Andersen (GSD4)
Diagnosis & Follow up
Information & Support
Research & Development
McArdle (GSD5)
Diagnosis & Follow up
Information & Support
Activity & Exercise
Research & Development
Hers (GSD6)
Diagnosis & Follow up
Information & Support
Research & Development
Tarui (GSD7)
Diagnosis & Follow up
Information & Support
Activity & Exercise
Research & Development
GSD9
Diagnosis & Follow up
Information & Support
Research & Development
Extra rare GSDs
GSD13
Danon
Lafora
Another GSD?
How we help
Support
Support
Our social media
Maps of GSD people
Information
Publications
Glisten magazine
Videos
Glossary of terms
Events
Calendar of events
Types of event
Conferences
The Main Event 2024
Feedback from our Main Event 2023
Winter Season 2022
Help us
Help us help
Register or join
Donate
Fundraise for us
Sponsor us
Volunteer for us
Contribute to website
Medical
Health professionals
COVID-19 coronavirus
COVID-19 infographic
RCGP eLearning
Medical Advisory Board
Research
Contact
Contact details
Message us form
Select Page
companies-house-logo
Home
>
Media
>
companies-house-logo
Monday, 15th October 2018
Choose a category
Choose a category
Select Category
Cori disease (15)
Exercise (7)
Fundraising (23)
GSD families (35)
Hers disease GSD6 (3)
International (10)
McArdle disease (26)
News (211)
Pompe disease (41)
Research (70)
Support (52)
Tarui disease (4)
Von Gierke disease (17)
Young people (22)
Recent news
Update on the Beam GSD1a programme.
27th August 2024
Virtual AGSD-UK support.
21st August 2024
Update on Spark Therapeutics Pompe gene therapy programme.
23rd July 2024
Update on phase 3 study of DTX401.
5th June 2024
International Pompe Day.
15th April 2024
Save the Date!
4th April 2024
Rare Disease Day 2024.
29th February 2024
Cipaglucosidase alfa (Pombiliti®) is accepted for use within NHS Scotland.
12th December 2023
Virtual Festive Event.
29th November 2023
Update on the DTX401 programme for GSD1a.
16th November 2023
Newborn Genomes Programme.
4th October 2023
NICE recommends cipaglucosidase alfa plus miglustat.
15th August 2023
New Continuum of Care Model for McArdle’s.
7th July 2023
Seminar for people affected by neuromuscular diseases.
17th May 2023
Main Event 2023 Programme
26th April 2023
The AGSD-UK website uses cookies:
Find out more.
Okay, thanks
